EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...
Some packages of Walmart-sold broccoli florets have been recalled by its manufacturer. The FDA has designated the recall as a ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
A major chocolate recall has been upgraded to the highest possible risk level.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The approval of Amneal Pharmaceuticals’ generic version of rifaximin 550 mg oral tablets is tentative due to the product’s ...
The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.